View Our Locations

614-501-6164

Paid Clinical Trials and Medical Research Studies
in Columbus OH, Phoenix AZ, and Erie PA

NASH Clinical Trial in Columbus

Nash Study

When liver cells store too much fat, the liver becomes inflamed and damaged. This is commonly the result of years of alcohol abuse, but a growing number of people are being diagnosed with a similar issue without the heavy drinking.

The term for this condition is nonalcoholic fatty liver disease, and it affects an estimated 80 to 100 million people. Nonalcoholic steatohepatitis, or NASH, is the most severe form of the disease. Once the condition reaches this stage, it can lead to scarring, fibrosis, liver cancer, cirrhosis, or liver failure.

NASH is linked to overweight or obesity, insulin resistance, high blood sugar, and high levels of fats in the blood. While some people experience fatigue or pain or swelling in the abdomen, most people do not display any symptoms, making NASH difficult to diagnose.

NASH Study Qualifications

Advances in drug therapy are key to treating this disease at its early stages and preventing further liver damage. If you have a suspected diagnosis of NASH, you may be interested in an upcoming study.

Participants must meet the following qualifications:

  • At least 18 years old
  • A suspected diagnosis of NASH
  • Cannot have known non-NASH liver diseases including:
    • Alcoholic liver disease
    • Autoimmune diseases
    • HIV
    • Active Hepatitis C

Participants may receive compensation for time and travel. To see if you or someone you know may qualify, please contact us at 614-501-6164 or complete our online volunteer form.

What Our Clients say

  • This is a great way to make extra money and be involved in a research study that will help and benefit many people to come. I’ve really enjoyed myself with the program and with the staff.

    V. Ivory
  • "Thank you for your courtesy and kindness. I felt confident and comfortable. I would recommend the research study here. My coordinator was awesome and very caring."

    HAB
  • Any stigma or hesitation about clinical research should be disregarded. A good learning program for research studies.

    DHC
  • It's a good way to find out if there's some new drugs that can help people that have problems like mine and the people here are just wonderful to work with.

    Jacqueline

Volunteer for a Clinical Trial